Detailed answers about VESINEX BIOSYSTEMS LTD, including incorporation, status, business activity, and accounts information.
When was VESINEX BIOSYSTEMS LTD founded?
VESINEX BIOSYSTEMS LTD was officially incorporated on 29 September 2026 and is registered under company number 17487028. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is VESINEX BIOSYSTEMS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of VESINEX BIOSYSTEMS LTD?
VESINEX BIOSYSTEMS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does VESINEX BIOSYSTEMS LTD do?
VESINEX BIOSYSTEMS LTD operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 72110 - Research and experimental development on biotechnology, 74909 - Other professional, scientific and technical activities n.e.c., 77400 - Leasing of intellectual property and similar products, except copyright works. These SIC codes provide insight into the company's business activities and industry focus.
What is VESINEX BIOSYSTEMS LTD's registered address?
The registered office address of VESINEX BIOSYSTEMS LTD is Bartle House, 9 Oxford Court, Manchester, England, M2 3WQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is VESINEX BIOSYSTEMS LTD financially stable?
Financial accounts for VESINEX BIOSYSTEMS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.